VWM
PACB icon

Venturi Wealth Management’s Pacific Biosciences PACB Stock Holding History

Venturi Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-18,800
Closed -$50K – 187
2017
Q4 		$50K Buy
+18,800
New +$65.8K 0.01% 191

Other funds holding PACB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return

Venturi Wealth Management's PACB Position: Q1 2018 in Review

Venturi Wealth Management sold out of Pacific Biosciences (PACB) in Q1 2018, closing a stake of 18,800 shares — an estimated $50K sold.

Venturi Wealth Management first reported a position in PACB in Q4 2017 and held it in 1 quarter. The position peaked at $50K in Q4 2017. 101 funds tracked by Wall St. Rank hold PACB as of Q1 2018.

  • Venturi Wealth Management reported no remaining Pacific Biosciences position as of Q1 2018 after selling out during the quarter.
  • Venturi Wealth Management sold 18,800 Pacific Biosciences shares in Q1 2018, an estimated $50K.
  • Venturi Wealth Management first reported a position in Pacific Biosciences in Q4 2017 and held it in 1 quarter.
  • Venturi Wealth Management's Pacific Biosciences position peaked at $50K in Q4 2017.
  • 101 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2018.

Based on Venturi Wealth Management's 13F filing for Q1 2018, filed 9 May 2018.